Escitalopram proves dominant over sertraline in MDD
Is it curtains for the blockbuster model?
According to the chief US drug regulator, Andrew von Eschenbach, the US government should not interfere
'Sunshine' laws bring little light to pharma payments
The American Heart Association (AHA) has announced updated guidelines
NFID urges increased flu vaccination in those with DM
NCCN oncology guidelines updated
Trastuzumab reimbursement decisions not equitable
Influenza virus vaccine uptake is low among healthcare workers in Victoria, Australia,
Atopic dermatitis costs significant for US employers
Aspirin has "favourable" cost utility in older women
Teenagers presenting for pregnancy termination are "no less responsible about contraceptive use"
Rizatriptan, eletriptan most cost-effective oral triptans for migraine?
Timely immunisation linked to parental satisfaction
Voriconazole best value for invasive aspergillosis in Spain
Pregnancy during isotretinoin use "frequent" in Canada
Antithrombotics are prescribed to most outpatients with permanent atrial fibrillation (AF), however the use of vitamin K antagonists decreases with age.
Nosocomial neonatal candidaemia increases hospital costs
Use of atorvastatin increases following PROVE-IT, REVERSAL
Many patients with DM missing lipid targets, missing treatment
Economics of expanded hepatitis A vaccination "reasonable"
UK NHS walk-in centres: no impact on primary care access
Clinical prescribing and the secondary prevention of PTSD
Hyperlipidaemia frequently undertreated after ED visits for ACS
News from CROI
The Australian government is to allocate approximately $A70 million* to community pharmacies
Cost of medicines rising in Austria
Costs of paediatric studies grow
Poland: 30% increase in healthcare funding
The Russian government has granted approval for a federal programme
Japan has announced a new contribution of $US186 million
A "full and far reaching" plan has been introduced by the South African government
Sanofi-aventis has announced that its cannabinoid 1 receptor antagonist, Acomplia [rimonabant],
WHO has issued new guidance calling for the introduction of pneumococcal conjugate vaccines into immunisation programmes for developing countries.